SMMT - CIK 0001599298
Summit Therapeutics Inc. has filed 532 documents with the SEC between 2014 and 2026. The most frequent type is 6-k (115 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Annual report to shareholders | ARS | 2025-04-29 | 2024-12-31 |
| Proxy statement | DEF 14A | 2025-04-29 | 2025-06-12 |
| Major company event | 8-K | 2025-04-25 | 2025-04-25 |
| Major company event | 8-K | 2025-04-23 | 2025-04-23 |
| Insider trade | 4 | 2025-04-09 | 2025-04-08 |
| Insider trade | 4 | 2025-04-09 | 2025-04-08 |
| Annual report | 10-K | 2025-02-24 | 2024-12-31 |
| Major company event | 8-K | 2025-02-24 | 2025-02-24 |
| Major company event | 8-K | 2025-01-24 | 2025-01-22 |
| SEC correspondence | UPLOAD | 2025-01-21 | - |
| Insider trade | 4 | 2025-01-14 | 2025-01-12 |
| Major company event | 8-K | 2025-01-13 | 2025-01-13 |
| Insider trade | 4 | 2025-01-06 | 2025-01-02 |
| Insider trade | 4 | 2025-01-06 | 2025-01-02 |
| Insider trade | 4 | 2025-01-06 | 2025-01-02 |
| Insider trade | 4 | 2025-01-06 | 2025-01-02 |
| Insider trade | 4 | 2025-01-06 | 2025-01-02 |
| Insider trade | 4 | 2025-01-06 | 2025-01-02 |
| Insider trade | 4 | 2025-01-06 | 2025-01-02 |
| Insider trade | 4 | 2025-01-06 | 2025-01-02 |
| Company correspondence | CORRESP | 2025-01-06 | - |
| SEC correspondence | UPLOAD | 2024-12-19 | - |
| Quarterly report | 10-Q | 2024-10-30 | 2024-09-30 |
| Major company event | 8-K | 2024-10-30 | 2024-10-30 |
| Insider trade | 4 | 2024-10-15 | 2024-10-11 |
| Insider trade | 4 | 2024-10-03 | 2024-10-03 |
| D | - | 2024-09-26 | - |
| S-3ASR | - | 2024-09-19 | - |
| Insider trade | 4 | 2024-09-13 | 2024-09-11 |
| Insider trade | 4 | 2024-09-13 | 2024-09-11 |
| Insider trade | 4 | 2024-09-13 | 2024-09-11 |
| Insider trade | 4 | 2024-09-13 | 2024-09-11 |
| Insider trade | 4 | 2024-09-13 | 2024-09-11 |
| Activist ownership stake (update) | SC 13D/A | 2024-09-13 | - |
| Major company event | 8-K | 2024-09-12 | 2024-09-11 |
| Major company event | 8-K | 2024-09-09 | 2024-09-08 |
| Insider trade | 4 | 2024-08-23 | 2024-08-23 |
| Insider trade | 4 | 2024-08-23 | 2024-08-23 |
| Quarterly report | 10-Q | 2024-08-06 | 2024-06-30 |
| Major company event | 8-K | 2024-08-06 | 2024-08-06 |
| S-3ASR | - | 2024-08-06 | - |
| Insider trade | 4 | 2024-06-27 | 2024-06-27 |
| New insider ownership | 3 | 2024-06-27 | 2024-06-27 |
| Major company event | 8-K | 2024-06-27 | 2024-06-27 |
| D | - | 2024-06-18 | - |
| Major company event | 8-K | 2024-06-17 | 2024-06-12 |
| Proxy materials | DEFA14A | 2024-06-13 | - |
| Major company event | 8-K | 2024-06-03 | 2024-06-03 |
| Major company event | 8-K | 2024-06-03 | 2024-05-31 |
| Major company event | 8-K | 2024-05-30 | 2024-05-30 |